AstraZeneca PLC

LSE-AZN

Operating Activities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Net Income	11,439	10,023	9,293	8,691	7,922	7,746
Profit Before Tax
Depreciation & Amortization	6,559	6,827	6,717	6,688	5,678	5,143
Depreciation, Amortisation and Impairment
Other Adjustments	1,700	1,964	2,049	1,438	2,126.5	1,715
Finance Income and Expense
Share of After Tax Income of Associates and Joint Ventures
Gains on Disposal of Intangible Assets
Gains on Disposal of Investments in Associates and Joint Ventures
Fair Value Movements on Contingent Consideration Arising from Business Combinations
Non-Cash and Other Movements
Changes in Trade Receivables	—	—	—	-1,624	—	—
Change in Trade and Other Receivables
Changes in Inventories	—	—	—	-131	—	—
Change in Inventories
Changes in Accounts Payable	—	—	—	862	—	—
Change in Trade and Other Payables and Provisions
Changes in Income Taxes Payable	-2,965	-2,962	-2,683	-2,750	-2,634	-2,642
Tax Paid
Changes in Other Operating Activities	-700	-1,540	-1,365	-1,313	-2,023	-1,018
Change in Working Capital and Short-Term Provisions
Interest Paid
Cash from Operating Activities	15,140	13,389	13,088	11,861	11,334	11,065
Net Cash Inflow from Operating Activities

Investing Activities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Capital Expenditure	-2,482	-2,213	-1,936	-1,924	-1,741	-1,643
Purchase of Property, Plant and Equipment
Proceeds from Sale of Property, Plant & Equipment	—	13	30.5	55	81.5	85.5
Disposal of Property, Plant and Equipment
Purchases of Intangible Assets	-3,091	-2,992	-2,014	-2,662	-2,836	-2,455
Purchase of Intangible Assets
Proceeds from Sale of Intangible Assets	112	143	94.5	123	147.5	117
Disposal of Intangible Assets
Purchases of Investments	-232.5	-231.5	-69.5	-96	-123	-177
Purchase of Non-Current Asset Investments
Proceeds from Sale of Investments	85	103	157	108	260	133
Disposal of Non-Current Asset Investments
Change in Short-Term Investments, Fixed Deposits and Other Investing Instruments
Payments for Business Acquisitions	-1,168	-1,163	-1,148	-3,782	-953	-902
Non-Contingent Payments on Business Combinations
Acquisition of Subsidiaries, Net of Cash Acquired
Payments Upon Vesting of Employee Share Awards Attributable to Business Combinations
Payment of Contingent Consideration from Business Combinations
Other Investing Activities	275	265	317	198	360	359
Change in Profit-Participation Liability
Payments to Associates and Joint Ventures
Disposal of Investments in Associates and Joint Ventures
Interest Received
Payments Made by Subsidiaries to Non-Controlling Interests
Cash from Investing Activities	-6,543	-6,056	-6,820	-7,980	-7,876	-7,583
Net Cash Inflow from Investing Activities

Financing Activities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Issuance of Long-Term Debt	—	2,283	4,762	6,492	—	—
Issue of Loans and Borrowings
Repayments of Long-Term Debt	-25	-2,025	-4,649	-4,652	-4,934	-4,177
Repayment of Loans and Borrowings
Net Issuance / (Repayments) of Long-Term Debt	-25	258	113	1,840	-4,934	-4,177
Issuance of Common Shares	40	39	40	38	36	36
Proceeds from Issue of Share Capital
Repurchases of Common Shares	-548.5	-610.5	—	-81	—	—
Own Shares Purchased by Employee Benefit Trusts
Net Issuance / (Repurchases) of Common Shares	-508.5	-571.5	40	-43	36	36
Common Share Dividends Paid	-4,794	-4,744	-4,807	-4,613	-4,639	-4,543
Dividends Paid
Hedge Contracts Relating to Dividend Payments
Other Financing Activities	423	-1,150	-256	-1,180	316	2,303
Payments to Acquire Non-Controlling Interests
Repayment of Obligations Under Leases
Change in Short-Term Borrowings
Payment of Acerta Pharma Share Purchase Liability
Cash from Financing Activities	-4,933	-6,991	-8,731	-3,996	-3,616	-2,211
Net Cash Inflow from Financing Activities